Vimarsana
Biggest News Aggregation in the World

Page 17 - Cell Lines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Lines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Lines Today - Breaking & Trending Today

MSNBC Morning Joe December 14, 2021 11:34:00 - Vimarsana News

MSNBC Morning Joe December 14, 2021 11:34:00

Antivaxers. the applicant explains they could not receive the vaccine because of their religion. >> oh, good lord. >> please, how stupid does he think we are. >> letecia james does not contain fetal cells. hek-293 cells are grown in the laboratory and thousands of generations removed from cells collected from a fetus in 1973 were used in the testing during the research and development phase of the pfizer and moderna vaccines. she added the use of fetal cell lines for testing is common including for rubella vaccines,

Tech transfer box ticked in Catalent and BrainStorm cell therapy alliance - Vimarsana News

Tech transfer box ticked in Catalent and BrainStorm cell therapy alliance

Catalent is reporting that the technology transfer for the manufacture of BrainStorm Cell Therapeutics’ autologous cellular therapy at its facility in Houston, Texas has been finalized.

Operations commence at new Genezen viral vector lab - Vimarsana News

Operations commence at new Genezen viral vector lab

Genezen, a cell and gene therapy focused CDMO, has just opened a new process development and analytical lab, a build that represents the first phase of a 75,000+ square foot cGMP-compliant lentiviral and retroviral vector production facility in Indianapolis.

Emulate enhances tech aimed at supporting disease research and drug development - Vimarsana News

Emulate enhances tech aimed at supporting disease research and drug development

Emulate, Inc recently launched the Zoë-CM2 Culture Module, a second-generation Zoë instrument core to its ‘Organ-on-a-Chip’ based Human Emulation System.

Sphere Fluidics closes $40m funding round - Vimarsana News

Sphere Fluidics closes $40m funding round

Sphere Fluidics, a UK company that has developed and is commercializing single cell analysis systems underpinned by its picodroplet technology, has just closed a US$40m investment round.